The immune landscape of the tumor microenvironment of urothelial carcinoma, including the infiltration level of immune cells, cytokine secretion, and PD-L1 expression, is associated with the ICI-treated response of patients with UC and other cancers (5). Here, CD274 is linked to cancer.